We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-1.7%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$439B
AUM Growth
+$49B
Cap. Flow
+$65.7B
Cap. Flow %
14.98%
Top 10 Hldgs %
33.97%
Holding
14,356
New
1,622
Increased
5,458
Reduced
5,222
Closed
1,858

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$703M
2
TSLA icon
Tesla
TSLA
+$585M
3
JPM icon
JPMorgan Chase
JPM
+$582M
4
AMZN icon
Amazon
AMZN
+$566M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$466M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$349M
2
HD icon
Home Depot
HD
+$334M
3
TMUS icon
T-Mobile US
TMUS
+$270M
4
CI icon
Cigna
CI
+$258M
5
CDW icon
CDW
CDW
+$237M

Sector Composition

Rank Sector Weight
1 Technology 3.12%
2 Healthcare 2.55%
3 Financials 2.39%
4 Consumer Discretionary 2.14%
5 Industrials 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ML
12076
PUT
DELISTED
MoneyLion Inc.
ML
$16K ﹤0.01%
587
-976
-62% -$44.8K
AHI
12077
DELISTED
Advanced Health Intelligence Ltd
AHI
$16K ﹤0.01%
+7,369
New +$19.5K
CEMI
12078
CALL
DELISTED
Chembio diagnostics, Inc.
CEMI
$16K ﹤0.01%
43,100
+24,400
+130% +$16.6K
HOOK
12079
CALL
DELISTED
HOOKIPA Pharma
HOOK
$15K ﹤0.01%
1,120
-1,390
-55% -$21.3K
INBS icon
12080
Intelligent Bio Solutions
INBS
$8.36M
$15K ﹤0.01%
+14
New +$21.2K
IVDA icon
12081
Iveda Solutions
IVDA
$4.94M
$15K ﹤0.01%
+3,001
New +$26.5K
JAGX icon
12082
CALL
Jaguar Health
JAGX
$4.5M
0
LVO icon
12083
CALL
LiveOne
LVO
$57.2M
$15K ﹤0.01%
2,070
-210
-9% -$2.22K
NUVB.WS
12084
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$15K ﹤0.01%
73,426
-289
-0.4% -$83
SPIR icon
12085
PUT
Spire Global
SPIR
$540M
$15K ﹤0.01%
1,750
-913
-34% -$9.9K
QNTM
12086
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$24.4M
$15K ﹤0.01%
276
-41
-13% -$2.41K
JXG
12087
JX Luxventure
JXG
$15K ﹤0.01%
+29
New +$20.7K
AAU
12088
DELISTED
Almaden Minerals Ltd
AAU
$15K ﹤0.01%
68,417
-18,154
-21% -$4.13K
UTRS
12089
DELISTED
Minerva Surgical, Inc. Common Stock
UTRS
$15K ﹤0.01%
+927
New +$35.1K
DOMA
12090
CALL
DELISTED
Doma Holdings, Inc.
DOMA
$15K ﹤0.01%
1,356
+440
+48% +$7.9K
APTO
12091
CALL
DELISTED
Aptose Biosciences, Inc.
APTO
$15K ﹤0.01%
55
-63
-53% -$21.7K
RMO
12092
PUT
DELISTED
Romeo Power, Inc.
RMO
$15K ﹤0.01%
37,600
-15,000
-29% -$9.03K
STEX
12093
Streamex Corp
STEX
$108M
$14K ﹤0.01%
+2,178
New +$16.9K
DTIL icon
12094
PUT
Precision BioSciences
DTIL
$205M
$14K ﹤0.01%
+363
New +$17.2K
EDBL
12095
Edible Garden
EDBL
$1.07M
0
ELTX icon
12096
Elicio Therapeutics
ELTX
$81.2M
$14K ﹤0.01%
1,468
-4,548
-76% -$47.5K
CYPH
12097
PUT
Cypherpunk Technologies Inc
CYPH
$69.4M
$14K ﹤0.01%
1,600
-1,820
-53% -$22.1K
MBRX icon
12098
Moleculin Biotech
MBRX
$4.35M
$14K ﹤0.01%
+36
New +$20.8K
JF
12099
J and Friends Holdings
JF
$17.4M
$14K ﹤0.01%
+52,738
New +$49K
PYPD icon
12100
PolyPid
PYPD
$90.9M
$14K ﹤0.01%
406
-470
-54% -$58.1K

Similar funds

Ken Griffin's Q3 2022 Portfolio in Review

As of Q3 2022, Ken Griffin held 14,356 positions worth $439B, up 13% from $390B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Ken Griffin deployed $65.7B of net new capital in Q3 2022, opening 1,622 new positions and adding to 5,458 existing holdings. Its largest new stake was SentinelOne: 4,426,634 shares worth $113M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 2.8% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $349M trimmed.

  • Ken Griffin's largest Q3 2022 buy was SentinelOne: 4,426,634 shares worth $113M.
  • Ken Griffin added most to Apple in Q3 2022, an estimated $703M increase.
  • Ken Griffin's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $349M.
  • Ken Griffin fully exited Regions Financial in Q3 2022, selling an estimated $207M.
  • Ken Griffin's ten largest holdings make up 34% of its $439B portfolio in Q3 2022.
  • Ken Griffin opened 1,622 new positions and closed 1,858 in Q3 2022.
  • Ken Griffin's portfolio value rose 13% quarter-over-quarter to $439B.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.